Published in J Clin Invest on November 01, 2001
The enigmatic X gene of hepatitis B virus. J Virol (2004) 2.98
Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol (2005) 2.94
Hepatitis B: the virus and disease. Hepatology (2009) 2.48
Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris) (2010) 2.48
Enhancement of hepatitis B virus replication by its X protein in transgenic mice. J Virol (2002) 1.78
Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. Proc Natl Acad Sci U S A (2009) 1.74
Hepatitis B virus X protein stimulates viral genome replication via a DDB1-dependent pathway distinct from that leading to cell death. J Virol (2005) 1.56
Molecular biology of hepatitis B virus infection. Virology (2015) 1.47
The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication. J Virol (2005) 1.43
Enhancement of hepatitis B virus replication by the regulatory X protein in vitro and in vivo. J Virol (2006) 1.27
Identification and characterization of avihepadnaviruses isolated from exotic anseriformes maintained in captivity. J Virol (2005) 1.26
Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges. Cancer Lett (2010) 1.22
Inhibition of cellular proteasome activities enhances hepadnavirus replication in an HBX-dependent manner. J Virol (2004) 1.15
Hepatitis B virus HBx protein localizes to mitochondria in primary rat hepatocytes and modulates mitochondrial membrane potential. J Virol (2008) 1.07
Activation of focal adhesion kinase by hepatitis B virus HBx protein: multiple functions in viral replication. J Virol (2006) 1.01
Hepatitis B virus HBx protein localized to the nucleus restores HBx-deficient virus replication in HepG2 cells and in vivo in hydrodynamically-injected mice. Virology (2009) 1.00
Enhancement of gene transactivation activity of androgen receptor by hepatitis B virus X protein. Virology (2007) 0.99
HBV induced HCC: major risk factors from genetic to molecular level. Biomed Res Int (2013) 0.92
Altered proteolysis and global gene expression in hepatitis B virus X transgenic mouse liver. J Virol (2006) 0.85
Hepatitis B virus HBx protein interactions with the ubiquitin proteasome system. Viruses (2014) 0.84
The C-terminal region of the hepatitis B virus X protein is essential for its stability and function. Virus Res (2010) 0.84
Inhibition of cellular proteasome activities mediates HBX-independent hepatitis B virus replication in vivo. J Virol (2010) 0.81
Animal models and the molecular biology of hepadnavirus infection. Cold Spring Harb Perspect Med (2015) 0.79
Hepatocyte Factor JMJD5 Regulates Hepatitis B Virus Replication through Interaction with HBx. J Virol (2016) 0.76
Hepatitis B virus molecular biology and pathogenesis. Hepatoma Res (2016) 0.75
Virology: The X-Files of hepatitis B. Nature (2016) 0.75
Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs. Nucleic Acids Res (1984) 39.52
Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res (1989) 15.35
HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature (1991) 5.34
Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity. J Virol (1990) 4.57
HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science (1991) 3.78
Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci U S A (1994) 3.76
Woodchuck hepatitis virus X protein is required for viral infection in vivo. J Virol (1994) 3.34
The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J Virol (1993) 2.84
Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature (1990) 2.69
The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. EMBO J (1995) 2.68
Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation. EMBO J (1995) 2.41
Effects of insertional and point mutations on the functions of the duck hepatitis B virus polymerase. J Virol (1990) 2.22
Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication. J Virol (1989) 2.21
Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases. Proc Natl Acad Sci U S A (1993) 2.06
Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases. J Virol (1996) 1.89
Biphasic clearance kinetics of hepatitis B virus from patients during adefovir dipivoxil therapy. Hepatology (1999) 1.86
The hepatitis B virus X-gene product trans-activates both RNA polymerase II and III promoters. EMBO J (1990) 1.84
Hepatitis B virus transactivator protein X interacts with the TATA-binding protein. Proc Natl Acad Sci U S A (1995) 1.72
Low dynamic state of viral competition in a chronic avian hepadnavirus infection. J Virol (2000) 1.66
Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation. J Virol (1995) 1.63
Proteasome complex as a potential cellular target of hepatitis B virus X protein. J Virol (1996) 1.62
Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex. J Virol (1999) 1.57
Molecular anatomy and pathophysiologic implications of drug resistance in hepatitis B virus infection. Gastroenterology (2001) 1.46
Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. J Virol (1994) 1.44
Complete nucleotide sequence of a molecular clone of woodchuck hepatitis virus that is infectious in the natural host. Proc Natl Acad Sci U S A (1989) 1.41
Structural and functional characterization of interaction between hepatitis B virus X protein and the proteasome complex. J Biol Chem (2000) 1.39
Alternate translation initiation on hepatitis B virus X mRNA produces multiple polypeptides that differentially transactivate class II and III promoters. J Virol (1992) 1.27
Kinetics of acute hepatitis B virus infection in humans. J Exp Med (2001) 1.26
Correct binding of viral X protein to UVDDB-p127 cellular protein is critical for efficient infection by hepatitis B viruses. Oncogene (2000) 1.22
Human hepatitis virus X gene encodes a regulatory domain that represses transactivation of X protein. J Biol Chem (1994) 1.21
Immunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection. J Virol (1999) 1.11
Hepatitis B virus precore mutation and fulminant hepatitis in the United States. A polymerase chain reaction-based assay for the detection of specific mutation. J Clin Invest (1994) 1.09
Duck hepatitis B virus expresses a regulatory HBx-like protein from a hidden open reading frame. J Virol (2001) 1.08
Identification of a protein isolated from senescent human cells that binds to hepatitis B virus X antigen. Hepatology (1998) 1.02
Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol Cell Biol (1999) 4.98
Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. Antimicrob Agents Chemother (2011) 4.21
Basal cell carcinomas in mice overexpressing sonic hedgehog. Science (1997) 3.84
Hepatocytes from non-hepatic adult stem cells. Nature (2000) 3.27
p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J Clin Invest (2001) 3.02
GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell (1996) 2.86
Delivery room management of the apparently vigorous meconium-stained neonate: results of the multicenter, international collaborative trial. Pediatrics (2000) 2.72
Hepatitis C virus structural proteins assemble into viruslike particles in insect cells. J Virol (1998) 2.71
Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc Natl Acad Sci U S A (1990) 2.59
A comprehensive map of the porcine genome. Genome Res (1996) 2.52
Long-term therapy of chronic hepatitis B with lamivudine. Hepatology (2000) 2.49
Altered triple helical structure of type I procollagen in lethal perinatal osteogenesis imperfecta. J Biol Chem (1985) 2.45
Long-term therapy of chronic delta hepatitis with peginterferon alfa. Aliment Pharmacol Ther (2014) 2.19
Protein trans-splicing by a split intein encoded in a split DnaE gene of Synechocystis sp. PCC6803. Proc Natl Acad Sci U S A (1998) 2.16
A novel hepatitis B virus (HBV) genetic element with Rev response element-like properties that is essential for expression of HBV gene products. Mol Cell Biol (1993) 2.12
I-cell disease: biochemical studies. Pediatr Res (1972) 2.08
[Evaluation of the degree of adherence to the Mediterranean diet in patients with heart failure: DIME-EAHFE study]. An Sist Sanit Navar (2016) 2.05
Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies. Leukemia (2010) 2.01
Selective deficits in the circadian light response in mice lacking PACAP. Am J Physiol Regul Integr Comp Physiol (2004) 2.01
Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease. Proc Natl Acad Sci U S A (2000) 2.00
Hepatitis B virus X protein is not central to the viral life cycle in vitro. J Virol (1992) 1.92
Expression of stem cell factor and its receptor, c-kit, during liver regeneration from putative stem cells in adult rat. Lab Invest (1994) 1.90
Design and performance evaluation of a whole-body Ingenuity TF PET-MRI system. Phys Med Biol (2011) 1.87
Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies. Leukemia (2013) 1.84
Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. Evidence that p47(phox) may participate in forming this oxidase in vitro and in vivo. J Biol Chem (1999) 1.73
Transformation by polyoma virus is drastically reduced by substitution of phenylalanine for tyrosine at residue 315 of middle-sized tumor antigen. Proc Natl Acad Sci U S A (1984) 1.71
4D embryonic cardiography using gated optical coherence tomography. Opt Express (2006) 1.71
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Clinical and laboratory features and response to treatment in patients presenting with vitamin B12 deficiency-related neurological syndromes. Neurol India (2005) 1.66
A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults. Vaccine (2010) 1.66
Expression of acidic fibroblast growth factor in regenerating liver and during hepatic differentiation. Lab Invest (1992) 1.63
Proteasome complex as a potential cellular target of hepatitis B virus X protein. J Virol (1996) 1.62
Synthesis and application of modulated polymer gels. Science (1995) 1.62
Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication. J Virol (1991) 1.61
Automatic, three-segment, MR-based attenuation correction for whole-body PET/MR data. Eur J Nucl Med Mol Imaging (2010) 1.59
Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex. J Virol (1999) 1.57
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis. Aliment Pharmacol Ther (2008) 1.54
A polyoma mutant that encodes small T antigen but not middle T antigen demonstrates uncoupling of cell surface and cytoskeletal changes associated with cell transformation. Mol Cell Biol (1984) 1.52
Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication. J Clin Invest (1996) 1.48
Endovascular stent-graft treatment for Stanford type A aortic dissection. Eur J Vasc Endovasc Surg (2011) 1.47
Molecular anatomy and pathophysiologic implications of drug resistance in hepatitis B virus infection. Gastroenterology (2001) 1.46
5-Hydroxytryptamine binding to synaptic membranes from rat brain. Life Sci (1976) 1.45
Emergence of a distinct pattern of viral mutations in chimpanzees infected with a homogeneous inoculum of hepatitis C virus. Gastroenterology (2001) 1.45
Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. J Virol (1994) 1.44
High-dose cisplatin in hypertonic saline. Ann Intern Med (1984) 1.43
Electromorphic characterization and description of conserved epitopes of the lipooligosaccharides of group A Neisseria meningitidis. Infect Immun (1988) 1.41
DNA vaccines and viral hepatitis: are we going around in circles? Gastroenterology (1997) 1.41
Determination of blood flow and endothelial shear stress in human coronary artery in vivo. J Invasive Cardiol (1999) 1.41
Recalculation of the temperature inside capillaries using high buffer concentrations. J Chromatogr A (2001) 1.39
Structural and functional characterization of interaction between hepatitis B virus X protein and the proteasome complex. J Biol Chem (2000) 1.39
National survey of the use of intraoperative antibiotics for prophylaxis against postoperative endophthalmitis following cataract surgery in the UK. Br J Ophthalmol (2010) 1.39
Activation of hepatic stem cell compartment in the rat: role of transforming growth factor alpha, hepatocyte growth factor, and acidic fibroblast growth factor in early proliferation. Cell Growth Differ (1993) 1.38
High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis. Br J Cancer (2007) 1.37
The sequence of the Helicoverpa armigera single nucleocapsid nucleopolyhedrovirus genome. J Gen Virol (2001) 1.37
Spin state transition in LaCoO3 studied using soft x-ray absorption spectroscopy and magnetic circular dichroism. Phys Rev Lett (2006) 1.36
Human selenoproteins at a glance. Cell Mol Life Sci (2005) 1.34
Precursor-product relationship between oval cells and hepatocytes: comparison between tritiated thymidine and bromodeoxyuridine as tracers. Carcinogenesis (1996) 1.29
Confidentiality: a survey in a research hospital. J Clin Ethics (1991) 1.29
Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidate. Gastroenterology (1999) 1.24
Microscopic origin of the giant ferroelectric polarization in tetragonal-like BiFeO(3). Phys Rev Lett (2011) 1.24
Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 1.23
Modulation of keratin 14 and alpha-fetoprotein expression during hepatic oval cell proliferation and liver regeneration. J Cell Physiol (1994) 1.22
Cloning, nucleotide sequence, and heterologous expression of the biosynthetic gene cluster for R1128, a non-steroidal estrogen receptor antagonist. Insights into an unusual priming mechanism. J Biol Chem (2000) 1.22
Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19
The metabolism of pyrene by rat liver microsomes and the influence of various mono-oxygenase inducers. Xenobiotica (1982) 1.19
Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2012) 1.19
Interactions controlling the membrane binding of basic protein domains: phenylalanine and the attachment of the myristoylated alanine-rich C-kinase substrate protein to interfaces. Biochemistry (1999) 1.19
Measurement of 3hJNC' connectivities across hydrogen bonds in a 30 kDa protein. J Biomol NMR (1999) 1.17
Design and synthesis of monocyclic beta-lactams as mechanism-based inhibitors of human cytomegalovirus protease. Bioorg Med Chem Lett (1998) 1.16
A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors. J Clin Oncol (1988) 1.16
Hepatic stem cell compartment: activation and lineage commitment. Proc Soc Exp Biol Med (1993) 1.16
The natural history of acute hepatitis C: clinical presentation, laboratory findings and treatment outcomes. Aliment Pharmacol Ther (2010) 1.14
Comparison of articaine and bupivacaine/lidocaine for sub-Tenon's anaesthesia in cataract extraction. Br J Anaesth (2004) 1.14
Study of immortalization and malignant transformation of human embryonic esophageal epithelial cells induced by HPV18 E6E7. J Cancer Res Clin Oncol (2000) 1.14
Hepatitis C virus-like particles induce virus-specific humoral and cellular immune responses in mice. Hepatology (2001) 1.13
Biomonitoring of polycyclic aromatic hydrocarbons in highly exposed coke plant workers by measurement of urinary phenanthrene and pyrene metabolites (phenols and dihydrodiols). Int Arch Occup Environ Health (1993) 1.13
Influence of hemodynamic factors on rupture of intracranial aneurysms: patient-specific 3D mirror aneurysms model computational fluid dynamics simulation. AJNR Am J Neuroradiol (2011) 1.12
Naturally occurring mutations define a novel function of the hepatitis B virus core promoter in core protein expression. J Virol (1998) 1.12
Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection. Hepatology (1991) 1.12
Beta3 integrins are upregulated after vascular injury and modulate thrombospondin- and thrombin-induced proliferation of cultured smooth muscle cells. Circulation (1998) 1.12
Functional analysis of the propeptide of subtilisin E as an intramolecular chaperone for protein folding. Refolding and inhibitory abilities of propeptide mutants. J Biol Chem (1995) 1.11
Dacryocystorhinostomy in south west England. Eye (Lond) (1998) 1.11
Gene organisation determines evolution of function in the chicken MHC. Immunol Rev (1999) 1.11
Steep rise in notified hantavirus infections in Germany, April 2010. Euro Surveill (2010) 1.10
Search for a W' or techni-ρ decaying into WZ in pp Collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2012) 1.10
Effect of asimadoline, a kappa opioid agonist, on pain induced by colonic distension in patients with irritable bowel syndrome. Aliment Pharmacol Ther (2004) 1.10
Localization of glucokinase-like immunoreactivity in the rat lower brain stem: for possible location of brain glucose-sensing mechanisms. Endocrinology (2000) 1.10
Biosynthesis of the anti-parasitic agent megalomicin: transformation of erythromycin to megalomicin in Saccharopolyspora erythraea. Mol Microbiol (2000) 1.10
Long-term outcome of chronic hepatitis C after sustained virological response to interferon-based therapy. Aliment Pharmacol Ther (2013) 1.09
p53 independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemia. Leukemia (2011) 1.09
Phase I study of taxol and granulocyte colony-stimulating factor in patients with refractory ovarian cancer. J Clin Oncol (1992) 1.09
Expression of transforming growth factor-alpha in regenerating liver and during hepatic differentiation. Mol Carcinog (1992) 1.09
Search for new physics with same-sign isolated dilepton events with jets and missing transverse energy. Phys Rev Lett (2012) 1.09
Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C. Hepatology (2000) 1.09
EM autoradiographic studies on polytene nuclei of Drosophila melanogaster. II. Organization and transcriptive activity of the chromocentre. Exp Cell Res (1974) 1.08
Stimulation of the mitogen-activated protein kinase cascade and tyrosine phosphorylation of the epidermal growth factor receptor by hepatopoietin. J Biol Chem (2000) 1.08
Search for supersymmetry at the LHC in events with jets and missing transverse energy. Phys Rev Lett (2011) 1.08